Skin Cancer Screening Practices Among Dermatologists: A Survey Study.

Abstract

The United States Preventative Task Force (USPTF) has concluded that the benefit of skin cancer screenings is inconclusive. A systematic review found that implementing skin cancer screening increased detection of in situ and thin melanoma, increased incidence of non-melanoma skin cancer detection, and decreased rates of thick melanoma. However, only one of the studies reviewed found a reduction in melanoma mortality. Evidence is notably unclear for the exact benefits of preventative skin cancer screening. This study intends to discover the current skin cancer screening practices and recommendations of dermatologists. A 20-question “Skin Cancer Screening Survey” was developed and sent to the American College of Mohs Surgery. 124 dermatologists completed the survey. The majority of physicians (77.4%) said they perform routine skin cancer screening exams. 37.9 % of respondents noted that they recommend routine skin cancer screenings to all their patients, while 27.4 % of participants recommend screening only patients with a risk factor. Most of the respondents (52.4%) stated that they do not follow any specific guidelines regarding routine skin cancer screenings. The majority selected that they usually perform full body skin exams (69.4%). Of those who answered that they do follow guidelines, most followed the American Academy of Dermatology guidelines (48.5%). 42.7% of respondents were aware of the USPTF recommendations regarding routine skin cancer screening. The results demonstrate variability in real world practice of skin cancer screening exams. There is imperative need for evidence-based uniform guidelines to drive accurate and unbiased preventative practice behaviors in the United States. J Drugs Dermatol. 2022;21(11):1235-1241. doi:10.36849/JDD.6660.